Answers are grounded in this paper and cite their sources.
Clinical success of cationic transfection lipids in nonviral gene therapy continues to remain critically dependent on the use of serum compatible cationic amphiphiles efficient in delivering genes into our body cells. To this end, we demonstrate that covalent grafting of simple Tris-base component of the widely used biological Tris buffer in the headgroup region is capable of imparting high serum compatibility and intravenous mouse lung transfection properties to cationic amphiphile.
No takes yet. Share an insight, caveat, or question.
Mukherjee et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: